Patients treated with TNFα antagonists increase their participation intThe work-force -: Potential for significant long-term indirect cost gains.: Data from a large population-based registry.

被引：0

|

作者：

van Vollenhoven, RF ^{[1
]}

Carli, CC ^{[1
]}

Augustsson, J ^{[1
]}

Bratt, J ^{[1
]}

Klareskog, L ^{[1
]}

机构：

[1] Karolinska Univ Hosp, Stockholm, Sweden

来源：

ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S737 / S737

页数：1

相关论文

共 3 条

[1] Patients treated with TNFA antagonists increase their participation in the work-force - Potential for significant long-term indirect cost gains
Van Vollenhoven, R. F.
Carli, C. Cullinane
Augustsson, J.
Braft, J.
Klareskog, L.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 511 - 511
[2] Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)
Augustsson, J.
Neovius, M.
Cullinane-Carli, C.
Eksborg, S.
van Vollenhoven, R. F.
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 126 - 131
[3] Treatment with TNFα antagonists results in significant gradual increases in work-force participation:: Data from the STURE registry.
van Vollenhoven, RF
Brannemark, S
Lindblad, S
Klareskog, L
ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S535 - S535